Partner in smart MDx assay development
Multiplex qPCR - Point of Care Applications - Antibiotic Resistance Detection
NYtor designs and develops molecular detection assays in the field of human and veterinary infectious disease diagnostics. Our main focus is the development of smart molecular assays for the detection of antibiotic resistance.
NYtor works with innovative technologies to enable development of ultra-sensitive and highly specific molecular diagnostics assays.
- Microbial diagnostics
With co-developing partners that perform final validation, CE-registration, production and sales
NYtor employs an enthusiastic and motivated team of PhDs and technicians with ample experience and state-of-the-art knowledge of MDx assay development
Assays available for commercialization:
• NG + quinolone resistance
• MG + macrolide and quinolone resistance
• CPE : KPC, OXA48 (including OXA181), VIM and NDM (+IMP)
• ESBL : CTX-M-1; CTX-M-2; CTX-M-9 groups and SHV-ESBL